Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online March 31, 2011.
Article Versions
- Latest version (March 10, 2011 - 07:01).
- You are currently viewing a Latest version of this article (March 31, 2011 - 06:37).
- View the most recent version of this article
Copyright & Usage
© 2011 American Society of Neuroradiology Indicates open access to non-subscribers at www.ajnr.org
Author Information
- From the Department of Radiology (L.C.H.C.), Clinics IRM, Clinica de Diagnóstico por Imagen and Multi-Imagem, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Imagen Médica Avanzada (I.R.), Madrid, Spain; Clinics Clinica de Diagnóstico por Imagen and Multi-Imagem (R.C.D.), Rio de Janeiro, Brazil; Department of Radiology (E.L.G.), Clinics Clinica de Diagnóstico por Imagen and Multi-Imagem, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; and Department of Radiology, (A.G.S.), Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts.
- Please address correspondence to L. Celso Hygino da Cruz Jr, MD, Rua Almirante Saddock de Sá 266, Ipanema, Rio de Janeiro, RJ, CEP:22411–040, Brazil; e-mail: celsohygino{at}hotmail.com
Altmetrics
Cited By...
Jump to section
Related Articles
Cited By...
- Clinical Translation of Hyperpolarized 13C Metabolic Probes for Glioma Imaging
- Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy
- Identification of a Single-Dose, Low-Flip-Angle-Based CBV Threshold for Fractional Tumor Burden Mapping in Recurrent Glioblastoma
- Diagnostic Accuracy of MR Spectroscopic Imaging and 18F-FET PET for Identifying Glioma: A Biopsy-Controlled Hybrid PET/MRI Study
- Distinguishing Progression from Pseudoprogression in Glioblastoma Using 18F-Fluciclovine PET
- Amino Acid PET in Neurooncology
- Amino Acid PET in Neurooncology
- Application of 7T MRS to High-Grade Gliomas
- Glioblastoma states are defined by cohabitating cellular populations with progression-, imaging- and sex-distinct patterns
- In vivo imaging of nanoparticle-labeled CAR T cells
- Pan-cancer imaging of TERT expression using deuterium magnetic resonance spectroscopy-based assessment of pyruvate metabolism
- PET/MRI Improves Management of Children with Cancer
- Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
- Spatiotemporal Heterogeneity in Multiparametric Physiologic MRI Is Associated with Patient Outcomes in IDH-Wildtype Glioblastoma
- 18F-FET PET Imaging in Differentiating Glioma Progression from Treatment-Related Changes: A Single-Center Experience
- A comprehensive proteomic SWATH-MS workflow for profiling blood extracellular vesicles: a new avenue for glioma tumour surveillance
- Dynamic Contrast-Enhanced MRI in Patients with Brain Metastases Undergoing Laser Interstitial Thermal Therapy: A Pilot Study
- Non-Contrast-Enhancing Tumor: A New Frontier in Glioblastoma Research
- Radiogenomics-based Risk Prediction of Glioblastoma Multiforme with Clinical Relevance
- Synthesizing a Contrast-Enhancement Map in Patients with High-Grade Gliomas Based on a Postcontrast MR Imaging Quantification Only
- Diagnostic Accuracy of Centrally Restricted Diffusion in the Differentiation of Treatment-Related Necrosis from Tumor Recurrence in High-Grade Gliomas
- Radiomics in Brain Tumor: Image Assessment, Quantitative Feature Descriptors, and Machine-Learning Approaches
- Detection of immune responses after immunotherapy in glioblastoma using PET and MRI
- Multiparametric Evaluation in Differentiating Glioma Recurrence from Treatment-Induced Necrosis Using Simultaneous 18F-FDG-PET/MRI: A Single-Institution Retrospective Study
- Preradiotherapy MR Imaging: A Prospective Pilot Study of the Usefulness of Performing an MR Examination Shortly before Radiation Therapy in Patients with Glioblastoma
- Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade Gliomas
- Temozolomide induces radiologic pseudoprogression and tumor cell vanishing in oligodendroglioma
- Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET
- Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI
- Parametric Response Mapping of Apparent Diffusion Coefficient as an Imaging Biomarker to Distinguish Pseudoprogression from True Tumor Progression in Peptide-Based Vaccine Therapy for Pediatric Diffuse Intrinsic Pontine Glioma
- Repeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed Glioblastoma
- Radiation Necrosis in Pediatric Patients with Brain Tumors Treated with Proton Radiotherapy
- Diffusion and Perfusion MRI to Differentiate Treatment-Related Changes Including Pseudoprogression from Recurrent Tumors in High-Grade Gliomas with Histopathologic Evidence
- Differentiation of Tumor Progression from Pseudoprogression in Patients with Posttreatment Glioblastoma Using Multiparametric Histogram Analysis
- In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma
- Longitudinal Restriction Spectrum Imaging Is Resistant to Pseudoresponse in Patients with High-Grade Gliomas Treated with Bevacizumab
- Response Classification Based on a Minimal Model of Glioblastoma Growth Is Prognostic for Clinical Outcomes and Distinguishes Progression from Pseudoprogression
- Imaging Changes in Very Young Children with Brain Tumors Treated with Proton Therapy and Chemotherapy
- Multimodal Magnetic Resonance Imaging and 18F-L-Dihydroxyphenylalanine Positron Emission Tomography in Early Characterization of Pseudoresponse and Nonenhancing Tumor Progression in a Pediatric Patient With Malignant Transformation of Ganglioglioma Treated With Bevacizumab
- Metabolic Response of Glioblastoma to Superselective Intra-Arterial Cerebral Infusion of Bevacizumab: A Proton MR Spectroscopic Imaging Study
- Late and Prolonged Pseudoprogression in Glioblastoma After Treatment With Lomustine and Temozolomide